Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Matutes

Showing results (31-40 of 316) with videos related to

Pageof 32
Sort By:
Oncology (Williston Park, N.Y.)|July 11, 2000
Pentostatin treatment of cutaneous T-cell lymphomaC Dearden, E Matutes, D Catovsky
British Journal of Cancer|November 1, 1991
Deoxycoformycin in the treatment of mature T-cell leukaemiasC Dearden, E Matutes, D Catovsky
British Journal of Haematology|October 1, 1983
The ultrastructural morphology of T lymphocytes in B-chronic lymphocytic leukaemia: a study with monoclonal antibodies and the immunogold techniqueE Matutes, A D Crockard, D Catovsky
Princess Takamatsu Symposia|January 1, 1984
Clinical, immunological, ultrastructural, and cytogenetic studies in black patients with adult T-cell leukemia/lymphomaE Matutes, V Brito-Babapulle, D Catovsky
Leukemia|June 2, 2006
Alemtuzumab in combination with high-dose methylprednisolone is a logical, feasible and highly active therapeutic regimen in chronic lymphocytic leukaemia patients with p53 defectsA R Pettitt, E Matutes, D Oscier
Leukemia & Lymphoma|July 1, 1993
Splenectomy in lymphoproliferative disorders: a report on 70 cases and review of the literatureJ E Coad, E Matutes, D Catovsky
British Journal of Haematology|September 1, 1996
Is T-cell CLL a disease entity?D Catovsky, E Matutes, V Brito-Babapulle
Seminars in Oncology|July 6, 2000
Clinical overview of pentostatin (Nipent) use in lymphoid malignanciesC E Dearden, E Matutes, D Catovsky
European Journal of Haematology|March 12, 2008
Prolymphocytic leukaemia of B- and T-cell subtype: a state-of-the-art paperM Dungarwalla, E Matutes, C E Dearden
Haematologica|May 18, 1999
Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disordersE Cabezudo, P Carrara, R Morilla, et al.
Pageof 32

Showing results (31-40 of 316) with videos related to

Sort By:
Pageof 32
Oncology (Williston Park, N.Y.)|July 11, 2000
Pentostatin treatment of cutaneous T-cell lymphomaC Dearden, E Matutes, D Catovsky
British Journal of Cancer|November 1, 1991
Deoxycoformycin in the treatment of mature T-cell leukaemiasC Dearden, E Matutes, D Catovsky
British Journal of Haematology|October 1, 1983
The ultrastructural morphology of T lymphocytes in B-chronic lymphocytic leukaemia: a study with monoclonal antibodies and the immunogold techniqueE Matutes, A D Crockard, D Catovsky
Princess Takamatsu Symposia|January 1, 1984
Clinical, immunological, ultrastructural, and cytogenetic studies in black patients with adult T-cell leukemia/lymphomaE Matutes, V Brito-Babapulle, D Catovsky
Leukemia|June 2, 2006
Alemtuzumab in combination with high-dose methylprednisolone is a logical, feasible and highly active therapeutic regimen in chronic lymphocytic leukaemia patients with p53 defectsA R Pettitt, E Matutes, D Oscier
Leukemia & Lymphoma|July 1, 1993
Splenectomy in lymphoproliferative disorders: a report on 70 cases and review of the literatureJ E Coad, E Matutes, D Catovsky
British Journal of Haematology|September 1, 1996
Is T-cell CLL a disease entity?D Catovsky, E Matutes, V Brito-Babapulle
Seminars in Oncology|July 6, 2000
Clinical overview of pentostatin (Nipent) use in lymphoid malignanciesC E Dearden, E Matutes, D Catovsky
European Journal of Haematology|March 12, 2008
Prolymphocytic leukaemia of B- and T-cell subtype: a state-of-the-art paperM Dungarwalla, E Matutes, C E Dearden
Haematologica|May 18, 1999
Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disordersE Cabezudo, P Carrara, R Morilla, et al.
Pageof 32